Lead design, development, and implementation of bioanalytical assays (LCMS, ELISA, qPCR, immunogenicity, cell-based biomarker, in vitro biomarker, etc.) to advance preclinical and clinical programs
Serve as bioanalytical subject matter expert supporting outsourced bioanalytical strategy, operations, and vendor management
Contribute to multiple drug programs and serve on cross-functional preclinical and clinical drug program teams
Select and manage vendors, oversee outsourced bioanalytical and biomarker methods, and ensure methods are developed and qualified/validated following FDA and ICH guidelines
Review and lead bioanalytical MD/MV reports and data summaries and collaborate with nonclinical toxicologists, clinical pharmacologists, and biostatisticians
Drive PK, PD, and immunogenicity testing strategy and ensure vendor qualification/validation work meets timelines and quality standards
Participate in planning, reviewing and authoring regulatory and clinical documents, abstracts, posters, protocols, and publications
Identify and resolve root causes of bioanalytical method issues and manage critical reagent life-cycle
Prepare and organize data for cross-functional presentation and communicate results to management, collaborators, and at scientific meetings
Provide bioanalytical expertise for diligence on external assets and potential in-licensing opportunities
Occasional travel required for collaboration, conferences and vendor oversight/audit; travel to Cambridge, MA office at least 3 times annually
Requirements
Ph.D. in biology, chemistry or a related field with at least 5 years, or MS with at least 7 years, of relevant scientific and technical experience in pharma/biotech/CRO environment
At least 2 years’ experience in biotech (non-negotiable)
Demonstrated experience developing and leading bioanalysis projects in support of preclinical lead nomination and IND-enabling, and clinical phase 1-3 for LCMS, ELISA, RT-qPCR, ADA, cell-based Nab, biomarker assays
Demonstrated previous bioanalytical method technical expertise in small molecule, anti-sense oligonucleotides, peptides, biologics (expert level preferred in at least 3 of 4)
Knowledge of preclinical and clinical drug development regulations with expert-level knowledge of the M10 BMV
Strong knowledge and experience with application of bioanalytical assay development, qualification/validation and sample analysis
Demonstrated experience with bioanalytical method documentation to support preclinical in vivo and clinical sample analysis
Experience working in a regulated (GxP) environment preferred but not required
Experience managing outsourced bioanalytical and biomarker vendor relationships and overseeing vendor deliverables
Experience preparing and reviewing MD/MV reports and data summaries
Experience identifying and resolving root causes of bioanalytical method issues; CAPA experience preferred
Strong interpersonal, communication and presentation skills
Ability to function in a biotech team environment and collaborate across departments
Previous experience contributing to regulatory documents and interacting with health authorities
Willingness and ability to travel up to 20% for vendor site-visits